Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Ritlecitinib is safe and may effectively treat alopecia areata.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

New and repurposed treatments are improving outcomes in dermatology.

Compound 4 is a promising treatment for hair loss with low toxicity.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Tofacitinib may help treat hair loss in children with alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Deucravacitinib helped a man regrow hair significantly.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

The ethyl acetate fraction of Ophioglossum vulgatum Linn. may promote hair growth and could be a new herbal treatment for hair loss.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.